Assetmark Inc. trimmed its position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 3.2% during the third quarter, HoldingsChannel reports. The fund owned 69,110 shares of the company’s stock after selling 2,304 shares during the quarter. Assetmark Inc.’s holdings in Corteva were worth $4,063,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Rovin Capital UT ADV boosted its position in shares of Corteva by 1.3% during the 3rd quarter. Rovin Capital UT ADV now owns 12,822 shares of the company’s stock worth $754,000 after purchasing an additional 168 shares in the last quarter. Capital Advisors Ltd. LLC grew its position in Corteva by 44.4% during the third quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company’s stock worth $33,000 after buying an additional 174 shares during the period. Pinnacle Bancorp Inc. increased its holdings in Corteva by 26.1% in the third quarter. Pinnacle Bancorp Inc. now owns 962 shares of the company’s stock valued at $57,000 after buying an additional 199 shares in the last quarter. Herr Investment Group LLC lifted its position in shares of Corteva by 2.8% during the 1st quarter. Herr Investment Group LLC now owns 7,400 shares of the company’s stock valued at $427,000 after acquiring an additional 200 shares during the period. Finally, Azzad Asset Management Inc. ADV boosted its stake in shares of Corteva by 0.4% during the 2nd quarter. Azzad Asset Management Inc. ADV now owns 48,200 shares of the company’s stock worth $2,600,000 after acquiring an additional 203 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
CTVA has been the subject of several research reports. UBS Group lifted their price objective on Corteva from $67.00 to $71.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Morgan Stanley reaffirmed an “overweight” rating and set a $65.00 price target on shares of Corteva in a research note on Tuesday, September 24th. Bank of America raised shares of Corteva from a “neutral” rating to a “buy” rating and increased their price objective for the company from $59.00 to $67.00 in a research note on Wednesday, October 16th. Barclays lifted their target price on shares of Corteva from $58.00 to $62.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Finally, Oppenheimer reissued an “outperform” rating and set a $70.00 price objective (up from $69.00) on shares of Corteva in a research note on Friday, November 8th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $63.68.
Corteva Trading Down 2.4 %
Shares of CTVA stock opened at $57.13 on Wednesday. The firm’s 50-day simple moving average is $58.22 and its 200-day simple moving average is $55.62. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.50 and a quick ratio of 1.17. Corteva, Inc. has a 1-year low of $43.22 and a 1-year high of $63.75. The firm has a market cap of $39.55 billion, a P/E ratio of 57.71, a PEG ratio of 1.72 and a beta of 0.77.
Corteva Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Monday, December 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date of this dividend is Monday, December 2nd. Corteva’s dividend payout ratio is currently 68.69%.
Corteva Company Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Featured Articles
- Five stocks we like better than Corteva
- What is the Euro STOXX 50 Index?
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What is MarketRankā¢? How to Use it
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Using the MarketBeat Dividend Yield Calculator
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.